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of all healthcare-associated infections each 
year. Despite recent improvements in 
healthcare, namely the use of broad spec-
trum antibiotics and the improvement of 
surgical techniques,[1,2] SSI continues to 
persist, posing an alarming threat to public 
health worldwide.[3,4] In addition, the eco-
nomic burden of patient hospital care is 
also significant.[4] Healthcare-associated 
infection costs related to SSI have been 
estimated to be on average €325 per day 
in Europe and $25 546 per infection in the 
United States.[4–6] The recurrent use of anti-
biotic therapeutic to treat microbial infec-
tions has led to the increase in microbial 
strain resistance, and thus, reducing antibi-
otic treatment efficacy.[3] One of the causes 
that contribute to the development of SSI 
could be the contamination during surgery 
or contamination of the medical devices 
even prior to implantation. The surfaces of 
medical devices can harbor pathogens, thus 
serving as a reservoir for infections.[7] The 
adherence of bacterial and the subsequent 
formation of biofilms on such devices 
occurs by the same process as the adhesive 
mechanism that facilitates host cell adher-
ence, proliferation, and growth.[8]
Current strategies to prevent SSI rely mostly on the local 
administration of antibiotics or antibacterial agents to the 
implant site.[9,10] The incorporation of antibiotics on fibers or as 
coatings in medical devices, like surgical sutures, help prevent 
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Surgical site infections (SSI) represent a serious health problem that occur 
after invasive surgery, thus new antimicrobial biomaterials able to prevent SSI 
are needed. Silks are natural biopolymers with excellent biocompatibility, low 
immunogenicity and controllable biodegradability. Spider silk-based materials 
can be bioengineered and functionalized with specific peptides, such as anti-
microbial peptides, creating innovative polymers. Herein, we explored new 
drug-free multifunctional silk films with antimicrobial properties, specifically 
tailored to hamper microbial infections. Different spider silk domains derived 
from the dragline sequence of the spider Nephila clavipes (6mer and 15mer, 
27 and 41 kDa proteins, respectively) were fused with the two antimicrobial 
peptides, Hepcidin (Hep) and Human Neutrophil peptide 1 (HNP1). The 
self-assembly features of the spider silk domains (β-sheets) were maintained 
after functionalization. The bioengineered 6mer-HNP1 protein demonstrated 
inhibitory effects against microbial pathogens. Silk-based films with 6mer-
HNP1 and different contents of silk fibroin (SF) significantly reduced bacterial 
adhesion and biofilm formation, whereas higher bacterial counts were found 
on the films prepared with 6mer or SF alone. The silk-based films showed 
no cytotoxic effects on human foreskin fibroblasts. The positive cellular 
response, together with structural and antimicrobial properties, highlight 
the potential of these multifunctional silk-based films as new materials for 
preventing SSI.
The ORCID identification number(s) for the author(s) of this article 
can be found under https://doi.org/10.1002/mabi.201800262.
1. Introduction
Surgical site infections (SSI) are one of the most serious com-
plications after post-transplant and surgery, accounting for 20% 
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the adherence and formation of microbial biofilms.[11,12] How-
ever, this approach may have a negative effect by increasing 
microbial resistance to antibiotics, ultimately failing to prevent 
SSI. There is a need to focus research on alternatives to anti-
biotics, by pursuing new antimicrobial agents with high effi-
ciency and less opportunity to develop bacterial resistance.[13] 
For instance, various types of antimicrobial polymeric coatings 
have been explored, such as polycationic polymers,[14] silver 
ions,[15] and antimicrobial peptides,[8] among others. Therefore, 
it is important to develop new biomaterials that are capable of 
preventing and controlling microbial proliferation on medical 
devices, and subsequently the formation of biofilms, without 
impairing wound healing, the proliferation of host cells, or 
encouraging microbial resistance.
The exploitation of novel polymers as anti-infective agents 
has progressively become a primary source of biomaterials. 
Natural polymers, such as spider silk and SF, among others, 
are already widely used for different medical applications.[16,17] 
Spider silk stands out as a unique class of structural proteins[18] 
due to its excellent biocompatibility, low immunogenicity, 
toughness, and ductility.[19,20] Among the different types of 
spider silk, the major ampullate dragline silk from Nephila 
clavipes is one of the most extensively studied silks due to the 
mechanical properties.[18] Similarly, SF is commonly used 
as a biomaterial due to its biocompatibility, biodegradability, 
mechanical properties, water vapor permeability, and minimal 
inflammatory response.[12,21]
Over the last decade, spider silk-based biomaterials were 
engineered and designed through recombinant DNA tech-
nology to suit different medical applications.[22] Microbial cells 
factories, and especially Escherichia coli endotoxin-free cultures, 
are versatile protein factories. They are easy to use as well as 
their cultivation is cost-effective, to support the scale-up pro-
duction of recombinant proteins.[23,24] With the aid of genetic 
and protein engineering, novel tailored-made strategies can be 
designed to suit user or process requirements.[25] Through this 
technique, new recombinant proteins with enhanced features 
can be synthesized while retaining the outstanding properties 
of the native spider silk.[26] For instance, genetically engineered 
spider silk proteins with biological domains to promote cell 
adhesion and proliferation,[27] formation of vascular tissue,[28] 
or bone regeneration[29,30] have been reported. Similarly, spider 
silk proteins functionalized with antimicrobial peptides were 
also designed to reduce or control biomaterial-associated infec-
tions.[19] In this previous work, the fusion of specific human 
antimicrobial peptides including human neutrophil defensin 2 
(HNP-2), human neutrophil defensin 4 (HNP-4), and hepcidin 
(Hep) with a spider silk domain demonstrated bactericidal 
activity against Gram- and Gram+ bacteria. By further investi-
gating these fusion proteins, multifunctional polymers can be 
envisaged as new drug-free biomaterials targeting a reduction 
in SSI.
The aim of this study was to investigate the potential of 
bioengineered spider silk proteins functionalized with antimi-
crobial peptides as drug-free films to prevent SSI. To achieve 
this goal, multifunctional, composite material, silk-based films 
were prepared by combining bioengineered spider silk pro-
teins with SF extracted from Bombyx mori cocoons. Herein, 
spider silk domains derived from the dragline sequence of the 
spider Nephila clavipes (6mer and 15mer) were fused with two 
antimicrobial peptides, Hep and Human Neutrophil peptide 
1 (HNP1), through cloning. The recombinant proteins were 
expressed, and their secondary structure as well as assembly 
and antimicrobial activity were evaluated. The bioengineered 
protein that demonstrated the best antimicrobial activity 
against well-known pathogens was used to study multifunc-
tional silk-based films with different percentages of SF. Bacte-
rial adhesion and the formation of biofilms on the multifunc-
tional silk-based films were determined, as well as cytotoxicity. 
With this new approach, we envisage that these new silk-based 
films can serve as a platform to engineer drug-free polymers 
for preventing SSI.
2. Experimental Section
2.1. Bioengineered Spider Silk Proteins Functionalized with 
Antimicrobial Peptides
2.1.1. Expression and Purification of Bioengineered Spider Silk 
Proteins Functionalized with Antimicrobial Peptides
The antimicrobial peptides, Hep, and HNP1 were individu-
ally inserted in pET30 vectors already carrying either six 
(6mer; 27 kDa) or fifteen (15mer; 41 kDa) repeats of the 
consensus sequence motifs derived from the major ampul-
late dragline silk I protein from Nephila clavipes (MaSp1; 
Accession number P19837).[31] Also, these spider silk blocks 
copolymers (6mer or 15mer) carried six histidine residues to 
facilitate protein purification, and two restriction sites, SpeI 
and NheI, flanking the edges for sub cloning of functional 
domains.[31] The cDNA sequence of the genes corresponding 
to the antimicrobial peptides of interest was selected based on 
the consensus motif derived from the back translation of Hep 
(Accession number P18172) and HNP-1 (Accession number 
P59665) proteins. Consensus sequences were obtained from 
the UniProt (http://www.uniprot.org/). The inserts, Hep and 
HNP1, were prepared through annealing of synthetic single 
strand oligonucleotides sequences. The oligonucleotides 
Hep-top, Hep-bot, HNP1-top, and HNP1-bot were chemi-
cally synthesized with 5’phosphorolated ends (Invitrogen). 
At the flanking edge of each oligonucleotide sequence, the 
restriction sites for NheI and SpeI were also included to facili-
tate the insertion of the oligonucleotide sequences into the 
pET30L vector, already containing the spider silk block of 
interest (6mer or 15mer). The annealing reactions containing 
a 20 pmol µL−1 oligonucleotide solution were carried by 
decreasing the temperature from 95 to 20 °C with a gradient 
of 0.1 °C s−1, and its presence was confirmed on 8% agarose 
gels.
Before the insertion of the different cDNA sequences (Hep 
or HNP1) into pET30L, the vectors containing either 6mer or 
15mer silk blocks were first digested with SpeI (New England 
Biolab), and dephosphorylated with calf intestinal phosphatase 
(CIP; New England Biolab) to prevent the re-circulation of the 
vector. The vector linearization was confirmed on a 0.8% aga-
rose gels and the linear vectors were further purified using the 
QIAquick gel extraction kit (Qiagen, CA, USA, 28 706). The 
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cDNA sequences of Hep and HNP-1 were ligated individually 
to the different silk coding block (6mer and 15mer) present in 
vector pET30L using T4 DNA ligase enzyme (New England Bio-
labs) overnight at 16 °C.
Competent cells E. coli DH5α (Invitrogen) were trans-
formed with the new ligation products (vector pET30L car-
rying 6mer, 6mer-Hep, 6mer-HNP1, 15mer, 15mer+ Hep, 
15mer+HPN-1). Transformants were spread onto LB agar 
plates with 50 µg mL−1 kanamycin, and incubated over-
night at 37 °C, for positive selection of the successful trans-
formants. The successful insertion of Hep or HNP-1 in the 
silk block vectors was confirmed by DNA sequencing, using 
T7 and T7 term primers. The bioengineered proteins were 
expressed in E. coli BL21De3 strain (Invitrogen). Overnight 
bacterial colonies previously grown 37 °C in 100 mL LB sup-
plemented with 50 µg mL−1 kanamycin, were used to inocu-
late 1 L of HyperBoth (0107; Athens Enzyme Systems Pro-
tein Expression) supplemented with 50 µg mL−1 kanamycin, 
and grown at 37 °C with 250 rpm agitation, until an OD600 
of 0.7–0.9 was reached. Protein expression was induced by 
adding isopropyl β-D-thiogalactoside (IPTG) at a final con-
centration of 1 mm for 4 h, and centrifuged at 8000 rpm for 
20 min at 4 °C. The cell pellet was stored at −20 °C overnight. 
Then, cell pellet was thawed in ice for 30 min, resuspended 
overnight in denaturating buffer (100 mm NaH2PO4, 10 mm 
Tris HCl, 8 m Urea, pH 8.0) at 4 °C, and the lysate superna-
tant was recovered by centrifugation at 8500 rpm for 30 min 
at 4 °C. A 50% Ni-NTA slurry in a ratio 1:4 (Ni-NTA:lysate) 
was added to the lysate, and mixed gently overnight at 4 °C. 
The supernatant/Ni-NTA resin mixture was added onto a 
glass Econo-column (Biorad). The mixture was washed four 
times with denaturing buffer (see above) at pH 6.3, and 
eluted with denaturating buffer at pH 5.8 and 4.5. Wash flow-
through and eluted fractions were analyzed by SDS-PAGE to 
confirm protein purification.
The purified proteins were dialyzed into cellulose ester snake 
skin membranes with a 100–500 Da molecular weight cutting 
off (Spectra/Por Biotech, 131 054), for one day, with 100 mm 
sodium phosphate buffer (pH 5.5), to keep a steady pH and 
avoid protein precipitation. Extensive dialysis against water was 
followed for three days to remove salts. Finally, the dialyzed 
proteins were lyophilized.
The expression levels and molecular weight of the new 
chimeric proteins were assessed by SDS-PAGE and Western-
blot, using a Bis-Tris 4–12% gel (NuPAge, Invitrogen). Gels 
were stained using Commassie blue staining for band detec-
tion. Western-Blot, bands from the SDS-PAGE were electro-
transferred onto a nitrocellulose membrane at 30 V for 16 h. 
Membranes were blocked for 1 h at 4 °C with a blocking solu-
tion (3% BSA or 5% Milk in TBS buffer). Then, the membrane 
was washed with TBS buffer and incubated for 1 h with mouse 
anti-histidine monoclonal antibody (1:100–1:3000 diluted in 
blocking solution). Membranes were again washed three times 
for 5 min with agitation with TBS buffer with Tween 20 (1 mL 
L−1 TBS), and incubated for 1 h with goat anti mousse IgG 
AP antibody (1:5000 dilution in blocking solution) with agita-
tion. Bands were detected in the membrane using a solution of 
5-bromo-4-chloro-3-indolylphosphate (BCIP) and nitrobluetet-
razolium (NBT).
2.1.2. Bioengineered Protein Secondary Structure
The secondary structure of bioengineered proteins was per-
formed by attenuated total reflection Fourier transform 
infrared spectroscopy (ATR-FTIR; IR Prestige-21 spectrom-
eter Shimadzu, Japan). The proteins 6mer-Hep, 6mer-HNP1, 
15mer-Hep, 15mer-HNP1, 6mer, and 15mer were dissolved 
in ultrapure water to a final concentration of 2% (w/v). 
Then, 50 µL of each protein solution was cast onto a non-
adherent polydimethylsiloxane surface and left to dry at room 
temperature. The protein films were treated with 90% meth-
anol treatment for 2 h to induce the transition of secondary 
structure from random coil to β-sheet. The spectra of the chi-
meric protein films were acquired in the absorbance mode in 
the range of 4000–400 cm−1 by averaging 100 individual scans 
per chimeric protein film at a resolution of 8 cm−1. The quanti-
fication of the secondary structure was based on the analysis of 
the amide I and amide II regions (1700–1450 cm−1). The quan-
tification of the secondary structure was based on the analysis 
of the amide I and amide II regions (1700–1450 cm−1). Col-
lected spectra were linear baseline corrected, normalized, and 
subsequently deconvoluted by fitting with a Lorentzian func-
tion using PeakFit software (Systat Software Inc., California, 
USA). The average percentage for the secondary structures, 
mainly β–sheet, random-coil/α-helix, and turns were calculated 
through the integration of the area of each deconvoluted peak 
curve, normalizing the obtained value to the total area of the 
amide I and amide II regions.[32] The secondary structure of the 
chimeric proteins was also analyzed by circular dichroism (CD 
– Model J1500, JASCO, Japan) spectroscopy. The spectra were 
collected between 190 and 260 nm with a step size of 1 nm, 
an averaging time of 1 s and five scans were collected for each 
sample. A baseline spectrum was subtracted from the samples. 
A sample cell with a 0.1 cm path length was used. Measure-
ments were performed in triplicate with 1 and 0.5 mg mL−1 
protein solution in phosphate buffer (pH 7.4).
2.1.3. Antimicrobial Activity of the Bioengineered Proteins
Radial diffusion assay: The antimicrobial activity of the bioen-
gineered proteins was evaluated against different well-known 
wound infecting pathogens, such as, Gram-negative bacteria 
(Pseudomonas aeruginosa, Escherichia coli), Gram-positive bac-
teria (Methicillin resistant S. aureus-MRSA, Vancomycin 
resistant S. aureus-VRSA, Enterococcus feacalis, Bacillus pumillus), 
and a fungus (Candida albicans). The Kirby–Bauer method was 
chosen but it was adapted from the original method for testing 
microbial resistance to antibiotic drugs. Microbial cultures were 
grown in Luria–Bertani (LB) broth medium at 37 °C overnight. 
Cells were centrifuged at 9000 rpm for 5 min at 4 °C, and then, 
the cell pellet was washed twice with sterile phosphate buffered 
saline solution (PBS; pH 7.4). The cell pellet was re-suspended 
in sterile PBS (pH 7.4), adjusted to an optical density of 0.3 (λ = 
610 nm) and spread onto Muller Hinton Agar (Oxoid, UK) with 
a sterile swab. Blank sterile disks (Oxoid, UK) were impregnated 
with 30 µL of different concentrations of the bioengineered pro-
teins (10, 50, 100, and 200 µg mL−1) and placed on top of the 
inoculated agar and incubated overnight at 37 °C. Experiments 
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were carried out in triplicates. Negative controls using either 
antibiotic impregnated disks (Vancomycin; Oxoid, UK) or PBS 
were also used. The diameter of the zone formed around the 
disks was measured to calculate the area of growth inhibition.
Bacterial viability in liquid media: further anain another factor 
of the bioengineered proteins on the microbial pathogens 
described above were also assessed in LB medium. Microbial 
cultures were grown overnight as mentioned earlier and centri-
fuged at 9000 rpm for 5 min at 4 °C. The cell pellets were sus-
pended in sterile PBS (pH 7.4), and adjusted to an optical den-
sity of 0.1 (λ = 610 nm). Then 50 µL of sterile solution of the 
bioengineered proteins at different concentration (10, 50, 100, 
and 200 µg mL−1) were added to 50 µL of microbial solution 
and incubated at 37 °C for 24 h with agitation (150 rpm). Bac-
terial growth was monitored by Optical density (OD 600 nm). 
Each experiment was performed in triplicate.
2.1.4. Aggregation and Zeta Potential of the Bioengineered Proteins
The assembly of 6mer-Hep, 6mer-HNP1, 15mer-Hep, 15mer-
HNP1, 6mer, and 15mer spider silk proteins was determined 
by dynamic light scattering (DLS) measurements using a Zeta-
sizer NanoZS instrument (ZEN3600, MALVERN Instruments, 
Worcestershire, UK). Different concentrations of each bioengi-
neered protein were prepared (10, 50, 100, and 200 µg mL−1) 
in ultrapure water. Scattering data was collected at a 173° scat-
tering angle. Three measurements were made per protein. The 
charge of each bioengineered protein sample was also deter-
mined by zeta potential measurements over the same range of 
protein concentrations, in triplicate.
2.2. Multifunctional Silk-Based Films
2.2.1. Silk Fibroin Extraction and Assembly of the Multifunctional 
Silk-Based Films
The multifunctional silk-based films were fabricated by 
combining lyophilized (SF) and the bioengineered proteins 
6mer and 6mer-HNP1. SF was extracted from raw cocoons 
of B. mori supplied from the Portuguese Association of Par-
ents and Friends of Mentally Disabled Citizens (APPACDM, 
Castelo Branco, Portugal) according to the procedure previ-
ously described.[33] Briefly, clean B. mori cocoons were cut into 
1 cm pieces and boiled in 0.02 m sodium carbonate solution for 
20 min at 0.25% (w/v) to remove sericin. Afterward, the deg-
ummed SF fibers were washed with deionized water for 20 min 
three times and dried in a fume hood overnight. The dried SF 
fibers were solubilized with a 9.3 m aqueous lithium bromide 
solution at 60 °C for 1 h. The solubilized SF were dialyzed 
against deionized water for three days using a 3500 g mol−1 
MWCO dialysis cassettes, until lithium bromide was com-
pletely removed. After dialysis, the aqueous SF solution was 
centrifuged twice at 8700 rpm at 5 °C for 25 min and decanted 
into a new tube to remove insoluble particulates. SF was lyo-
philized and kept at room temperature, until further use. The 
multifunctional films were prepared by combining 2% (w/v) 
of the bioengineered spider silk proteins 6mer-HNP1 or 6mers 
in HFIP (Sigma) with different contents of SF, 10%, 12%, or 
15%, (w/v) by gentle mixing into solution prior to casting. Also, 
control films were prepared with only 10%, 12%, or 15% SF 
and used as controls, since they did not have any bioengineered 
spider silk protein. Films were prepared by casting a 100 µL 
aliquot of the silk-based HFIP protein solution onto a 10 mm 
microplate coated with PDMS and air dried for 24 h.
2.2.2. Secondary Structure of the Silk-Based Films
The secondary structure of the multifunctional silk-based films 
was assessed by ATR-FTIR, as previously described. The char-
acterization was performed before and after annealing with 
90% methanol for 2 h, analyzing amide I and amide II regions 
(1700 to 1450 cm−1). The baseline of the silk-based films spectra 
were corrected and normalized before peaks fit deconvolution 
with the Lorentzian function in PeakFit, as described in above.
2.2.3. Scanning electron microscopy (SEM) of the silk-based films
The morphological characterization of the multifunctional silk-
based films was by SEM (JSM-6010LV, JEOL, Japan). Prior to 
SEM observations, the silk-based films were coated with plat-
inum by ion sputtering (EM ACE600, Leica, Germany).
2.2.4. Atomic Force Microscopy (AFM) of the Silk-Based Films
The AFM measurements were conducted on a Bruker AFM 
(Dimension Icon) with NanoScope Analysis software v1.5 
(Bruker). The surface topography of the silk-based films (5 × 
5 µm2) was performed in PeakForce Tapping (ScanAsyst) in 
air with silicon nitride cantilevers (ScanAsyst-Air, Bruker) with 
spring constant of 0.4 N m−1 and frequency of 70 kHz. The 
roughness measurements were analyzed with NanoScope Anal-
ysis software v1.5 where the root-mean-square (Rms) and the 
arithmetic average height (Ra) of the films were measured. Rms 
indicates the standard deviation of the height values within a 
specific area, and determines the surface roughness.[34,35]Ra is 
a commonly used roughness parameter, defined as the average 
deviation of the roughness irregularities from the mean line 
over the sampling length.[34,35]
2.2.5. Bacteria Viability and Adherence on the Silk-Based Films
Prior to the bacterial tests, the silk-based films were previ-
ously sterilized by immersion in a 70% ethanol solution for 
2 h, washed three times with sterile PBS (pH 7.4) and dried 
overnight. The viability of bacteria grown on the surface of the 
silk-based films was assessed against Methicillin resistant S. 
aureus (MRSA). Before seeding, all films were hydrated in PBS 
(pH 7.4). Then, films were incubated with 200 µL of bacteria 
inoculum, previously adjusted to an optical density of 0.1 (λ = 
610 nm) at 37 °C with agitation (150 rpm) for 24 h. Afterward, 
the films were washed three times with PBS and stained with 
200 µL solution of a Live/Dead Bacterial Viability Kit (Molecular 
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probes, L7007, Invitrogen) for 15 min at room temperature. 
After staining, the films were washed three times with sterile 
PBS (pH 7.4) to remove excess fluorescence dye. Live bac-
teria were stained green using SYTO 9 and Dead bacteria 
were stained red using PI and visualized using a Fluorescence 
Microscope (Imager Z1m, Zeiss), under 40× magnification. 
For each film type, four random images were acquired using 
a digital camera (AxioCam MRm5, Zeiss). ImageJ (NIH, Mary-
land, USA) was used for all image processing. Bacterial viability 
was calculated as the ratio of the live to dead bacteria. SEM was 
used to evaluate MRSA adherence and biofilm formation on 
the surface of the silk-based films after 24 h growth at 37 °C in 
Luria–Bertani broth (LB) medium. After incubation, silk-based 
films were removed from the LB medium and washed twice 
with sterile PBS (pH 7.4). Films were fixed with 4% glutaralde-
hyde for 60 min in the dark at room temperature. Then, films 
were dehydrated in a series of ethanol–water solutions (20%, 
40%, 50%, 70%, 90%, 100%, v/v), and left to dry overnight 
prior to coat with palladium by ion sputtering.
2.2.6. Cytotoxicity Assay
The biological impact of the silk-based films on human foreskin 
fibroblasts (HFF) was assessed. HFFs are an immortalized cell 
line and (American Type Culture Collection) the silk-based films 
were sterilized as described in Section 2.5. Prior to cell seeding, 
cells were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% (v/v) fetal bovine serum, 1% 
penicillin streptomycin (v/v) at 37 °C with 5% CO2 in a humidi-
fied environment. When confluence was reached, cells were 
trypsinized (0.25% trypsin/EDTA solution) from the culture 
flask. Sterile silk-based films were cultured in a 24-well plate with 
100 µL of a cell suspension containing 40 000 cells and incubated 
for 4 h at 37 °C with 5% CO2 in a humidified environment. After-
ward, 900 µL of DMEM was added to each well and incubated for 
1 and 3 days under the same conditions as described above. Cells 
cultured onto tissue culture polystyrene (TCPS) with standard 
culture medium were used as a negative control. Cell growth 
and adherence were evaluated after 1 and 3 days of incubation, 
respectively, using phase contrast light microscopy (Leica).
Cell proliferation was evaluated by dsDNA picogreen quan-
tification (P11495, Invitrogen), according to the manufacturer’s 
instructions. After each incubation time, DMEM medium was 
removed from each well and the cells were washed twice with 
sterile PBS (pH 7.4). Then, 1 mL of ultrapure water was added to 
each well to induce complete membrane lysis, incubated at 37 °C 
for 1 h and stored at −80 °C until further analysis. After thawing, 
samples were analyzed for DNA content and measured at an 
excitation wavelength of 485/20 nm and at an emission wave-
length of 528/20 nm. DNA content was calculated according to a 
standard curve. Samples without cells were used as control.
HFF metabolic activity was determined by Alamar Blue assay 
(DAL1100, Invitrogen) according to the manufacture instruc-
tions. After each culture time, DMEM medium was removed 
from each well and the cells were washed twice with sterile 
PBS (pH 7.4). Then, 1000 µL of Alamar Blue solution (1/10 in 
DMEM; v/v) was added directly to each well and incubated for 
4 h at 37 °C with 5% CO2. The metabolic activity was recorded 
by fluorescence at an excitation wavelength of 570 nm and emis-
sion at 585 nm, and normalized by DNA content to account for 
variation in cell number. The experiments were run in triplicate.
2.3. Statistical Analysis
All the quantitative results were obtained from triplicate sam-
ples. Data are reported as mean ± standard deviation and tested 
for normality. For statistical analysis, a one-way ANOVA test 
was performed using GraphPad Prism 6.0 software and the dif-
ferences were considered statistically significant if p < 0.05.
3. Results and Discussion
3.1. Characterization of Bioengineered Spider Silk Proteins 
Fused with Antimicrobial Peptides
One of the major characteristics of biomaterials with anti-infec-
tive properties is related to the need to prevent the adherence 
of microbial pathogens and the formation of biofilms.[8,36] New 
bioengineered spider silk proteins with antimicrobial proper-
ties offer an advantage, since they are specifically tailored to 
prevent SSI, while also avoiding systemic exposure to antibi-
otics. However, the full potential for this approach needs to be 
further investigated.
Through recombinant DNA technology, new bioengineered 
spider silk proteins 6mer-HNP1, 15mer-Hep, and 15mer-
HNP1 were successfully produced (Figure 1). The expression 
and purification of the chimeric proteins 6mer, 15mer, 6mer-
hepcidin, 6mer-HNP-1, 15mer-Hepcidin, and 15mer-HNP-1 
was assessed with SDS-PAGE (Figure 1A) and Western blots 
(Figure 1B). The molecular weights of the chimeric proteins 
6mer, 6mer+hepcidin, 6mer-HNP-1, 15mer, 15mer-hepcidin, 
and 15mer-HNP-1 were 27, 29, 29, 41, 44, and 44 kDa, respec-
tively (Figure 1C).
The ATR-FTIR spectra of the 6mer, 6mer-Hep, 6mer-HNP1, 
15mer, 15mer-Hep, and 15mer-HNP1 protein films were 
measured before and after methanol treatment, and exhibited 
strong amide I (1700–1600 cm−1) and amide II (1600–1500 
cm−1) regions (Figure 2A). Before methanol treatment, the 
spectra for the chimeric proteins films with antimicrobial pep-
tides (6mer-Hep, 6mer-HNP1, 15mer-Hep, and 15mer-HNP1) 
exhibited vibrational modes in the range of 1650–1647 cm−1, 
of the amide I region, which indicated helix/random coil con-
formations. After methanol treatment, these peaks appeared in 
the range of 1620–1630 cm−1, in the amide I region, and in 
the range of 1510–1530 cm−1, in the amide II region, indica-
tive of antiparallel β-sheet structures (Figure 2A), confirming 
the structural transition of the protein to the aqueous-stable 
features.[19,37] Also, the spectral deconvolution of the bioen-
gineered proteins was made (Figure 2B,C). After methanol 
treatment, antiparallel β-sheet content increased whereas a 
decrease in α-helix/random coil conformation was observed 
in the bioengineered proteins with the 6mer or 15mer spider 
silk domains (Figure 2B,C). The β-sheet content in the protein 
films after methanol treatment in the 6mer domains was 40.5% 
for 6mer, 49.8% for 6mer-Hep, 46.4% 6mer-HNP1, whereas in 
Macromol. Biosci. 2018, 1800262
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Figure 2. Characterization of the bioengineered proteins. A) ATR-FTIR spectra of the bioengineered spider silk proteins before and after methanol 
treatment; B) Percentage of β-sheet and random coil/helix conformations after spectra deconvolution of 6mer, 6mer-Hep and 6mer-HNP1 proteins; 
C) Percentage of β-sheet and random coil/helix conformations after spectra deconvolution of 15mer, 15mer-Hep, and 15mer-HNP1 proteins; D) CD 
spectra of the bioengineered spider silk proteins 6mer, 6mer-Hep and 6mer-HNP1 in phosphate buffer (pH 7.4); E) CD spectra of the bioengineered 
spider silk proteins 15mer, 15mer-Hep, and 15mer-HNP1 in phosphate buffer (pH 7.4).
Figure 1. a) SDS-PAGE gel stained with colloidal blue and b) Western-blot using anti-histidine antibody. Legend: M: Lambda DNA/HindIII Marker 
(ThermoFisher); 1: 6mer; 2: 6mer-Hep; 3: 6mer-HNP1, 4: 15mer; 5: 15mer-Hep; 6: 15mer-HNP1. c) Amino acid sequence of the bioengineered spider 
silk proteins.
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the 15mer domains were 53.4% for 15mer, 51.3% for 15mer-
Hep, and 56.4% for 15mer-HNP1. The higher β-sheet confor-
mations after methanol treatment promoted structure stability 
and water insolubility demonstrate that the core self-assem-
bling of the spider motif maintained the formation of β-sheet 
crystals in the new bioengineered proteins.[19,31] Results dem-
onstrate that the spider silk domains, 6mer, and 15mer were 
able to keep their self-assembly features after functionalization 
with the antimicrobial peptides. Regarding the bioengineered 
proteins with antimicrobial peptides, the values of β-sheet con-
tent were similar to the ones obtained in the 6mer and 15mer 
controls, suggesting that the addition of the antimicrobial pep-
tides had no influence on structural conformation of the new 
bioengineered proteins after methanol treatment.
The CD spectra of the bioengineered proteins, 6mer, 6mer-
Hep, 6mer-HNP1, 15mer, 15mer-Hep, and 15mer-HNP1 were 
obtained in phosphate buffer (pH 7.4) (Figure 2D,E). In the case 
of 6mer, a predominant β and α conformation was observed, 
with two minima at 198–205 and 215 nm (Figure 2D). The 
6mer-Hep and 6mer-HNP1 proteins showed a negative ellip-
ticity, with a minimum of 195–200 nm (Figure 2D). These 
results for assembly and secondary structure are consistent 
with previous studies.[19,38] The presence of a β-conformation in 
the 6mers proteins suggests that two or more disulphide bonds 
were present in the antimicrobial domain,[38] thus inferring that 
protein folding was maintained. The same result was reported 
on previous studies with silk fusion proteins.[19,39]
Also in the 15mer fusion protein (Figure 2E), the pres-
ence of a negative elasticity with a minimum of 200 nm sug-
gested a random coil configuration, with a negative shoulder 
at 220 nm, thus indicating the presence of additional struc-
tures like α-helix or β-sheet.[40] However, in the 15mer pro-
teins with the antimicrobial peptides, 15mer-Hep, and 15mer-
HNP1, a positive ellipticity with a maximum of 195–200 nm 
and a negative ellipticity with a minimum of 210 nm was 
detected (Figure 2E). These results suggest that the insertion 
of the antimicrobial peptides may have caused protein confor-
mation to change, possibly due to the formation of disulfide 
linkage.
3.2. Antimicrobial Activity of the Bioengineered Spider 
Silk Proteins
The antimicrobial activity of the bioengineered spider silk pro-
teins was assessed against VRSA, MRSA, E. feacalis, B. pumillus, 
E. coli, P. aeruginosa, and C. albicans using the radial diffusion 
assay (Figure 3 and S1, Supporting Information; Table 1).
In the present study, 6mer-HNP1 protein showed higher bac-
terial activity against Gram+ bacteria (i.e., MRSA) than to Gram- 
bacteria (e.g., P. aeruginosa) at a range of concentration (10 to 
200 µg mL−1) (Figure 3; Table 1). For the other bioengineered 
proteins, a microbial inhibitory effect was only observed at the 
highest concentrations tested (100–200 µg mL−1).
Macromol. Biosci. 2018, 1800262
Figure 3. Representative image of the antimicrobial activity of 6mer and 6mer-HNP1 bioengineered proteins against VRSA, MRSA, E. feacalis, B. 
pumillus, P. aeruginosa, E. coli, and C. albicans, using radial diffusion assay. Protein concentrations were 10, 50, 100, and 200 µg mL−1. Proteins 6mer 
and 15mer were used as controls. Blank disks (Oxoid) with 8 mm were used. Red dash-line indicates the formation of the zone of growth inhibition.
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The antimicrobial activity of HNP1 varied when fused with 
different spider silk domains. 15mer-HNP1 only showed anti-
microbial activity against VRSA, B. pumillus, and C. albicans 
growth at the concentration of 200 µg mL−1 (Figure S1, Sup-
porting Information; Table 1). Further analysis of antimicro-
bial activity of the bioengineered proteins was carried out in 
liquid LB medium (Figure S2, Supporting Information). An 
inhibitory growth effect of 6mer-HNP1 protein was observed 
against MRSA, VRSA, E. feacalis, B. pumillus, E. coli, P. aer-
uginosa, and C. albicans, corroborating the our earlier findings 
that this protein has broad antimicrobial activity. The shift in 
protein conformation of the bioengineered protein 15mer-
HNP1 could have resulted in reduced antimicrobial activity 
compared to 6mer-HNP1 protein, suggesting that the anti-
microbial activity of HNP1 varied when fused with different 
spider silk domains. Also, while the secondary structure of the 
bioengineered proteins remained similar in the 6mer proteins, 
the CD data (Figure 2E) showed that the protein configuration 
of 6mer and 15mer proteins changed due to the formation of 
disulfide bonds, suggesting that protein folding may have inter-
fered with the antimicrobial potential of Hep and HNP1.[41,42] 
The 6mer-Hep and 15mer-Hep proteins also demonstrated the 
same inhibiting effect on VRSA, B. pumillus, and C. albicans at 
higher concentration (200 µg mL−1) as 15mer-HNP1 (Figure 
S1, Supporting Information; Table 1). Hep antibacterial activity 
has been linked to stabilization of the 3D structure provided by 
the intramolecular disulfide bridges bonds, whereas in HNP1, 
the order of connectivity between the three disulphide bonds 
does not impair HNP1 peptide antimicrobial activity.[38] Never-
theless, the results from our study suggest that by fusion with 
6mer or 15mer spider silk motifs, the antimicrobial activity was 
lower when compared to the 6mer-HNP1 protein activity. This 
may be due to protein folding, making the antimicrobial pep-
tide site less available and thus less bioactive.
In the present study, only 6mer-HNP1 had broad antimi-
crobial activity against the tested microorganisms. The other 
proteins with Hep (6mer-Hep and 15mer-hep) and HNP1 
(15mer-HNP1) showed antimicrobial activity against specific 
microorganisms. HNP1 peptides are known to be more prone 
to kill S. aureus (Gram+ bacteria) than against Gram- bacteria 
Macromol. Biosci. 2018, 1800262
Table 1. Evaluation of the antimicrobial activity of the bioengineered spider silk proteins with antimicrobial peptides against microbial pathogens.
Microorganisms Concentration [µg mL−1] Diameter of the inhibition zone [mm]
6mer 6mer-Hep 6mer-HNP1 15mer 15mer-Hep 15mer-HNP1
VRSA 10 0 0 0 0 0 0
50 0 0 0 0 0 0
100 0 0 2 0 0 0
200 0 2 2 0 1 2
MRSA 10 0 0 0 0 0 0
50 0 0 2 0 0 0
100 0 0 3 0 0 0
200 0 0 4 0 0 0
E. faecalis 10 0 0 0 0 0 0
50 0 0 0 0 0 0
100 0 0 2 0 0 0
200 0 0 5 0 0 0
B. pumillus 10 0 0 2 0 0 0
50 0 0 2 0 0 0
100 0 0 2 0 0 0
200 0 3 3 0 1 2
P. aeruginosa 10 0 0 0 0 0 0
50 0 0 0 0 0 0
100 0 0 2 0 0 0
200 0 0 4 0 0 0
E. coli 10 0 0 0 0 0 0
50 0 0 0 0 0 0
100 0 0 1 0 0 0
200 0 0 2 0 0 0
C. albicans 10 0 0 0 0 0 0
50 0 0 0 0 0 0
100 0 0 0 0 0 0
200 0 3 3 0 1 2
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as well as virus and fungi.[41] The mechanism of action has 
not been completely identified, although previous studies sug-
gested that the antimicrobial potential could be due to binding 
to membrane precursor lipid II present on cell membranes and 
leading to membrane permeability as well as inhibiting meta-
bolic process.[42,43] 6mer-HNP1 also inhibited the growth of E. 
coli and P. aeruginosa, but at a higher concentrations (Figure 3, 
Table 1), further corroborating our finding that Gram+ bacteria 
are more susceptible to 6mer-HNP1 peptides. Nevertheless, it 
is not clear how these bioengineered spider silk proteins affect 
bacteria and further investigation is needed to clarify this issue.
Also, in the present study, the protein 6mer-Hep only showed 
antimicrobial activity against VRSA and C. albicans (Figure 3, 
Table 1), suggesting that the antimicrobial potential of this pro-
tein could be dependent of the microorganism strain tested. 
Gomes et al.[19] reported that the functionalization of spider silk 
domain 6mer with Hepcidin demonstrated an inhibitory effect 
against Gram- bacteria rather than Gram+. Hep was previously 
described to have antibacterial activity. This is a natural human 
host defense peptide known to act as an iron regulatory hor-
mone, and to have a broad spectrum of antimicrobial activity 
against E. coli, S. epidermidis, S. aureus, and group B strepto-
cocci, as well as fungi.[44,45]
3.3. Aggregation and Charge of the Bioengineered Proteins
Another factor that can interfere with the antimicrobial activity 
of the bioengineered proteins is the formation of aggregates 
and the protein surface charge.[19] DLS analysis was used to 
assess the aggregation of 6mer-Hep, 6mer-HNP1, 15mer-Hep, 
and 15mer-HNP1 proteins, since the assembly state could 
impact antimicrobial activity (Figure 4).
Results showed that the increase of particle diameter of the 
6mer, 6mer-Hep, 6mer-HNP1, 15mer, 15mer-Hep, and 15mer-
HNP1 was dependent of concentration (Figure 4). The presence 
of the spider silk domains can explain this behavior, since silk 
proteins are known to self-assemble in solution with increased 
concentration.[19] Of the 6mer and 15mer proteins functional-
ized either with Hep or HNP1 peptides, two different particle 
sizes were detected. The proteins 6mer-Hepcidn and 15mer-
Hepcidin showed a smaller particle size when compared to the 
silk-alone proteins 6mer or 15mer, whereas the 6mer-HNP1 
and 15mer-HNP1 showed an increase in size. Protein aggrega-
tion increased at higher concentrations, which can affect anti-
microbial capacity interfering with protein surface charges as 
well as with the proper folding of the bioengineered proteins, 
rendering them less active against pathogens.
These results could be explained by the presence of the dif-
ferent antimicrobial domains, resulting in a variation of assem-
bled sizes, influencing the number of charged amino acids. 
Therefore, the surface charge of the bioengineered proteins 
was evaluated with the same concentrations as used for the 
antimicrobial tests (Table 2).
The protein 6mer showed a neutral zeta potential at the 
lowest concentrations tested, becoming relatively negatively 
charged at concentrations of 50–200 µg mL−1. As for the 15mer, 
it showed a relative negative charge on all tested concentra-
tions. As for the 6mer-Hep, the protein surface showed a nega-
tive surface charge at the different concentrations tested (10–
200 µg mL−1), while 6mer-HNP1 protein presented a positive 
surface charge through all the concentrations tested. The same 
positively charged trend was also observed with the protein 
surface of 15mer-Hep at the tested concentrations. The protein 
15mer-HNP1 presented a positive charge at 10–50 µg mL−1, 
which shifted to a negative charged surface at higher concentra-
tions (100–200 µg mL−1) (Table 2).
The protein 6mer showed a neutral zeta potential at the lowest 
concentrations tested, becoming relatively negative-charged at 
concentrations 50–200 µg mL−1. As for the protein 15mer, it 
showed a relative negative-charged surface protein on all tested 
concentrations. As for 6mer-Hep, the protein surface showed an 
induced negative surface charge at the different concentrations 
tested (10–200 µg mL−1), while 6mer-HNP1 protein presented 
a positive surface charge through all the concentrations tested. 
The same positively charged trend was also observed with the 
protein surface of 15mer-Hep at the tested concentrations. The 
protein 15mer-HNP1 presented a positive charge at concen-
trations 10–50 µg mL−1, which shifted to a negatively charged 
surface at higher concentrations (100–200 µg mL−1) (Table 2). 
These results suggest that the presence of the antimicrobial 
peptides in the spider silk domain block could have an impact 
on protein surface charge, possibly due to the reorganization of 
the exposed monomers at the protein surface. The presence of 
the different antimicrobial domains can increased or decreased 
the number of charged amino acids at the surface, resulting in a 
variation of protein size and charged. In fact, positively charged 
surface attract negatively charged bacterial cells, while negative-
charged surfaces repel such cells,[46] which can affect the anti-
microbial properties of the bioengineered proteins. Also, the 
integrity of the microbial cell wall can become compromised by 
the adsorption of such positive-charged peptides.[46] In the pre-
sent study, only the bioengineered protein 6mer-HNP1 demon-
strated a broad antimicrobial activity against the several bacteria 
and a fungus, while the other proteins (6mer-Hep, 15mer-Hep, 
and 15mer-HNP1) showed a less inhibitory effect on tested 
pathogens, possibly due to a decrease on function property of 
the bioengineered proteins.
3.4. Multifunctional Silk-Based Films with Antimicrobial 
Properties
Since there is an urgent need to develop biomaterials capable of 
impeding SSI by preventing adherence and biofilm formation 
by microbial pathogens,[8] multifunctional silk-based films with 
antimicrobial properties were generated by combining 6mer-
HNP1 protein with a broad antimicrobial activity as mentioned 
above, with different contents of SF (10%, 12%, and 15%). By 
engineering novel polymers with intrinsic antimicrobial or 
anti-infective properties, new and smarter biomaterials can be 
developed. In the present study, SF was chosen as a backbone 
structure in order to develop multifunctional films, since this 
natural protein polymer has outstanding properties and has 
been widely used to produce different types of biomaterials 
from films to fibers and other variants.[12]
The secondary structure of the silk-based films was assessed 
by ATR-FTIR (Figure 5A), where an increase in β-sheet content 
Macromol. Biosci. 2018, 1800262
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in the amide I and amide II regions after methanol treatment 
was found. On all films, the average percentage for the secondary 
structures, mainly β-sheet content, was calculated through the 
integration of the area of each deconvoluted curve, normalizing 
the obtained value to the total area of the amide I and amide 
II regions. Spectra deconvolution revealed the decrease of helix/
random coil conformations and increase of antiparallel β-sheet 
structures on all the developed films after methanol treatment 
(Figure 5A), as expected. These results suggest that the combina-
tion of SF with the bioengineered spider silk protein does not 
interfere with the formation of antiparallel β-sheet.
One of the most important parameters that can influ-
ence microbial adhesion and biofilm formation is related to 
the surface of medical devices.[47] Herein, we assessed the surface 
morphology and topography of the multifunctional silk-based 
films by SEM and AFM (Figure 5B,C). In the SEM micrographs 
of the silk films containing only SF (10%, 12%, and 15% SF), it 
was possible to detect the presence of small aggregates from silk 
Macromol. Biosci. 2018, 1800262
Figure 4. DLS measures of particle diameter (nm) as a function of protein concentration. Blue dots correspond to particles diameters from the aggre-
gation of high charge molecules, whereas orange dots correspond to particles diameters from the aggregation of lower charge molecules.
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materials at the films surface (Figure 5B). As for the silk-based 
films containing 6mer or 6mer-HNP1, the surface morphology 
was homogenous, with the exception of the films containing 
15%SF and 6mer-HNP1, where some aggregates were also 
detected (Figure 5B). As for the AFM topographic images, the 
silk-based films with the bioengineered proteins (6mer or 6mer-
HNP1) presented a smoother surface when compared to the SF 
alone surface (Figure 5B and Table 3).
The control films made with only different SF contents 
showed the formation of aggregates at the film surface 
(Figure 5B). The surface roughness values RMS and RA 
(calculated from the height images) of the silk films made with 
10–12% SF and the bioengineered spider proteins, 6mer and 
6mer-HNP1 were significantly (p < 0.05) lower than the control 
films with only 10–12% SF. Also, the silk-based films prepared 
with 6mer or 6mer-HNP1 showed a similar smoother surface 
(Table 3). These results suggest that the presence of the proteins 
6mer or 6mer-HNP1 have higher surface smoothness than the 
SF films. However, the same trend was not observed in the 15% 
silk-based films containing 6mer, 6mer-HNP1, or SF alone, 
where the roughness values RMS and Ra values showed no 
significant differences (p > 0.05). Nevertheless, the enhanced 
roughness surface values in these films could be related to an 
increase of silk fibrils due to the higher content in silk (15%).
Macromol. Biosci. 2018, 1800262
Table 2. Zeta potential of the bioengineered spider silk proteins in H2O at 25 °C.
Bioengineered spider silk protein Protein concentration [µm mL−1]
10 50 100 200
6mer 0.14 ± 3.14 −9.69 ± 4.40 −2.30 ± 0.74 −1.05 ± 0.512
6mer-Hep −1.31 ± 0.26 −3.74 ± 2.54 −3.49 ± 0.37 −10.9 ± 1.50
6mer-HNP1 4.79 ± 0.35 5.04 ± 0.21 8.95 ± 0.88 6.09 ± 0.23
15mer −1.43 ± 1.35 1.49 ± 0.24 −1.16 ± 0.37 −1.43 ± 0.17
15mer-Hep 3.29 ± 0.22 9.83 ± 0.37 14.5 ± 0.25 9.85 ± 0.46
15mer-HNP1 9.25 ± 0.24 6.98 ± 0.63 −3.72 ± 1.05 −1.74 ± 0.63
Figure 5. Characterization of the silk-based films made with 10% SF + 2% 6mer, 12% SF + 2% 6mer, 15% SF + 6mer, 10% SF + 2% 6mer-HNP1, 12% 
SF + 2% 6mer-HNP1, 15% SF + 6mer-HNP1. Films prepared with only 10%, 12%, and 15% SF were used as controls. A) Percentage of β-sheet, turns 
and random coil/helix conformations after ATR-FTIR spectra deconvolution of the silk-based films. Spectra conformation were assessed before and 
after methanol treatment; B) SEM micrographs of multifunctional silk-based films with 10%, 12% and 15% SF combined with 6mer or 6mer-HNP1 
proteins. The scale bar corresponds to 10 µm in the main image and 1 µm in the insets; C) AFM topographies of multifunctional silk-based films. The 
scale bar corresponds to 1 µm.
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3.5. Bacterial Viability and Adherence to the Multifunctional 
Silk-Based Films
As mentioned earlier, the prevention of bacterial infections by 
reducing bacteria adherence or inactivation is one of the strate-
gies that needs to be further investigated.[47] Since lower surface 
roughness could influence cell adherence as well as bacterial 
adherence, the viability and adherence of MRSA on the sur-
face of the silk-based films was investigated after 24 h growth 
(Figure 6).
The silk-based films with 6mer and 6mer-HNP1 proteins 
showed significantly lower bacteria viability when compared 
to the films with SF alone (Figure 6A,B). In the silk-based 
films with 6mer or 6mer-HNP1, bacterial viability was similar 
Table 3. Surface Roughness, RMS, and Ra for the multifunctional films.
Film Rms [nm] Ra [nm]
10% SF SF only 22.6 ± 2.82 a 14.9 ± 1.24 a
6mer 5.95 ± 0.62 b 4.17 ± 0.20 b
6mer-HNP1 5.14 ± 1.39 b 3.32 ± 0.69 b
12% SF SF only 16.0 ± 3.07 a 12.5 ± 2.36 a
6mer 3.47 ± 0.84 b 2.56 ± 0.61 b
6mer-HNP1 4.81 ± 0.52 b 3.46 ± 0.18 b
15% SF SF only 18.0 ± 12.2 a 9.91 ± 6.90 a
6mer 12.0 ± 2.77 a 8.82 ± 2.03 a
6mer-HNP1 7.08 ± 0.69 a 5.13 ± 0.58 a
Rms: root mean square; Ra: arithmetic average height. Means ± SD with different letters in the same column differed significantly according to Tukey’s Multiple Range test 
at p < 0.05
Figure 6. MRSA viability on the silk-based films made with 10% SF + 2% 6mer, 12% SF + 2% 6mer, 15% SF + 6mer, 10% SF + 2% 6mer-HNP1, 12% 
SF + 2% 6mer-HNP1, 15% SF + 6mer-HNP1. Films prepared with only 10%, 12%, and 15% SF were used as controls. A) Representative images of 
MRSA adherence and biofilm formation. Live bacteria were stained green using SYTO 9 and Dead bacteria were stained red using PI. The scale bar 
correspond to 50 µm; B) Percentage of viability of MRSA after 24 h at 37 °C; C) SEM micrographs showing the formation of biofilm and bacterial 
adherence of MRSA on the silk-based films after 24 h at 37 °C. White arrows point bacteria adhesion. The scale bar corresponds to 50 µm in the main 
image and 10 µm in the insets.
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(Figure 6B). The formation of a bacterial biofilm on the films 
containing only SF (10%, 12%, and 15%) was observed by SEM 
after 24 h of incubation (Figure 6C). The films containing 6mer 
and 6mer-HNP1 proteins supported less bacterial adherence, 
the 10% and 12% SF films made with 6mer-HNP1 were lower 
than those with 6mer (Figure 6C). Also, no biofilm formation 
was observed on these films with the exception of films con-
taining 15% SF and 6mer-HNP1 (Figure 6C).
These multifunctional silk-based films functionalized with 
the bioengineered 6mer-HNP1 significantly decreased the 
adherence and proliferation of MRSA, as well as the formation 
of biofilms when compared to films prepared with SF alone or 
functionalized with 6mer protein (Figure 6). This effect could 
be attributed to the antimicrobial potential of the functional-
ized spider silk protein 6mer-HNP1. Moreover, higher surface 
roughness can result in more bacteria adherence, leading to the 
formation of biofilms and SSI.[48] In the present study, the sur-
face roughness of the multifunctional silk films with the bioen-
gineered proteins was significant lower (p < 0.05) than in the 
silk films with only SF. These results could explain the reduc-
tion in adherence and proliferation of Gram+ bacteria on the 
films with the bioengineered proteins. Also, this can translate 
to a reduction of risk of infection. Furthermore, lower viable 
counts of MRSA were observed on films with 6mer-HNP1 
when compared to the films with 6mer, suggesting that 6mer-
HNP1 offers an advantage for utility for new antimicrobial 
biomaterials.
3.6. Cytotoxicity of the Multifunctional Silk-Based Films
The cytotoxic response to the silk-based films was evaluated 
using human foreskin fibroblasts (HFF) (Figure 7).
DNA content was quantified to evaluate cell proliferation 
(Figure 7A). An increase in DNA content was observed over time 
in culture, indicating cell proliferation. However, after 7 days of 
growth, the amount of DNA was lower in the silk-based films 
when compared to the positive controls (Plastic) without any 
Figure 7. A) Cellular viability/proliferation (Alamar Blue assay) and B) Double strand DNA (dsDNA) quantification assay of HFFs cultured on the 
multifunctional silk-based films after 1 and 3 days in DMEM medium. Plastic stands for tissue culture plastic, used as a positive control. Columns with 
different letters differed significantly according to Tukey Multiple Range test at p < 0.05.
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silk-based films. The metabolic activity of HFF showed no signif-
icant differences when grown on the different films (Figure 7B). 
These results demonstrate that the increase in SF content in the 
presence of the bioengineered proteins 6mer and 6mer-HNP1 
were still able to support mammalian cell proliferation.
The response of HFF to the multifunctional silk films 
showed no significant effect (Figure 7), indicating that these 
multifunctional silk-based films containing 6mer or 6mer-
HNP1 supported mammalian cell adhesion and prolifera-
tion. These results, together with the antimicrobial properties 
of the multifunctional silk films, suggest that it is possible to 
tailor novel biomaterials to prevent biofilm formation, without 
impairing mammalian cell growth and proliferation.
In summary, the outcomes of this study indicate that 
6mer-HNP1 in combination with SF-generated new, drug-
free polymers, tailored to reduce microbial adhesion and bio-
film formation, without impairing mammalian cell growth 
and proliferation. These materials pose advantageous alterna-
tives for medical devices to prevent or reduce SSI, without 
the extensive use of antibiotics.[8] Nevertheless, it is necessary 
to further investigate the requisites of how these new antimi-
crobial biomaterials respond to infection in a clinical setting.
4. Conclusion
The present study investigates the potential of using multifunc-
tional silk films with bioengineered spider silk proteins fused 
with antimicrobial peptides to prevent SSI. Through recom-
binant DNA technology, it was possible to design and specifi-
cally tailor new spider silk materials for this task. These new 
bioengineered proteins retained native spider silk properties, 
mainly the formation of β-sheet, which confers exceptional 
mechanical properties, and also, the antimicrobial activity of 
the fused peptides. When combined with SF, the protein 6mer-
HNP1 prevented the adherence and formation of bacterial bio-
films. Further, bacterial viability on the films with 6mer-HNP1 
was significantly reduced compare with SF films alone or 
combined with 6mer. Moreover, the proliferation of HFFs was 
also sustained on the films, suggesting these new materials as 
intriguing candidates for new drug-free polymers with antimi-
crobial properties. In fact, the importance of this investigation 
relies on the ability to engineer smart materials able to prevent 
biofilm formation while supporting cellular proliferation. It 
is necessary to further expand this investigation to determine 
mechanistically how these multifunctional silk materials affect 
the formation of bacterial biofilms, including the effect on 
Gram+ bacteria, thus preventing SSI.
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